Efficacy of blockade of thoracoabdominal nerves through perichondrial approach (TAPA) for postoperative analgesia in pediatric abdominal surgeries
Not Applicable
Recruiting
- Conditions
- SurgeryPaediatricsAnaesthesia
- Registration Number
- PACTR202110874021535
- Lead Sponsor
- Mansoura university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1)Aged between 1-7 years old.
2)Either sex.
3)American Society of Anesthesiology (ASA) I and II patients.
4)Scheduled for pediatric abdominal surgery.
Exclusion Criteria
1)Parental refusal of consent.
2)Hyperactive airway disease or respiratory diseases.
3)Children with developmental delays, mental or neurological disorders.
4)Bleeding or coagulation diathesis.
5)History of known sensitivity to the used anesthetics.
6)Infection or redness at the injection site.
7) Anatomic anomalies or liver diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie TAPA's analgesic effects compared to TAP in pediatric abdominal surgery?
How does TAPA efficacy compare to TAP in reducing postoperative pain scores and opioid use in pediatric patients?
Which biomarkers correlate with successful thoracoabdominal nerve blockade via TAPA in pediatric surgical populations?
What adverse events are associated with perichondrial approach nerve blocks versus TAP in pediatric abdominal procedures?
Are adjuvant drugs like bupivacaine or clonidine synergistic with TAPA for enhanced postoperative analgesia in pediatrics?